Ignite Creation Date:
2024-05-06 @ 1:26 PM
Last Modification Date:
2024-10-26 @ 1:14 PM
Study NCT ID:
NCT04028245
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2019-07-18
Brief Title:
A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma
Sponsor:
Columbia University
Organization:
Columbia University
Organization Data
Organization:
Columbia University
Class:
OTHER
Study ID:
AAAS2814
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Columbia University
Lead Sponsor Class:
OTHER
Responsible Party:
Karie D Runcie MD
Responsible Party Title:
Assistant Professor of Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Columbia University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis | INDUSTRY |